KTTA icon

Pasithea Therapeutics

7 hedge funds and large institutions have $1.09M invested in Pasithea Therapeutics in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
KPF
1
K2 Principal Fund
Ontario, Canada
$973K 550,000 +550,000 New
TRCT
2
Tower Research Capital (TRC)
New York
$52K 29,385 +27,551 +1,502%
Vanguard Group
3
Vanguard Group
Pennsylvania
$22K 12,700 +12,700 New
HF
4
HRT Financial
New York
$22K 12,731 +12,731 New
BlackRock
5
BlackRock
New York
$15K 8,502 +8,502 New
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$2K 1,000 +1,000 New
KC
7
Kepos Capital
New York
-400,000 Closed
TSS
8
Two Sigma Securities
New York
-10,440 Closed
UBS Group
9
UBS Group
Switzerland
-3,290 Closed
CFGS
10
Concourse Financial Group Securities
Alabama
Wells Fargo
11
Wells Fargo
California
$0 30 +30 New